Key Performance
More- Earnings Score: 14
- Momentum Score: 39
- True Yield: N/A
- Financial Health Score: 16
%20scale(1,1)}%2025%25%20{transform:%20translate(24.943161px,19.954806px)%20scale(0.85,0.85)}%2050%25%20{transform:%20translate(24.943161px,19.954806px)%20scale(0.7,0.7)}%2075%25%20{transform:%20translate(24.943161px,19.954806px)%20scale(0.85,0.85)}%20100%25%20{transform:%20translate(24.943161px,19.954806px)%20scale(1,1)}}%20%23ewMkZ6d8Hun3_ts%20{animation:%20ewMkZ6d8Hun3_ts__ts%204000ms%20linear%20infinite%20normal%20forwards}@keyframes%20ewMkZ6d8Hun3_ts__ts%20{%200%25%20{transform:%20translate(24.9787px,20.012362px)%20scale(1,1)}%2025%25%20{transform:%20translate(24.9787px,20.012362px)%20scale(0.85,0.85)}%2050%25%20{transform:%20translate(24.9787px,20.012362px)%20scale(0.7,0.7)}%2075%25%20{transform:%20translate(24.9787px,20.012362px)%20scale(0.85,0.85)}%20100%25%20{transform:%20translate(24.9787px,20.012362px)%20scale(1,1)}}%20]]%3e%3c/style%3e%3cdefs%3e%3clinearGradient%20id='ewMkZ6d8Hun2-fill'%20x1='12.5'%20y1='23.5001'%20x2='-0.868518'%20y2='16.4047'%20spreadMethod='pad'%20gradientUnits='userSpaceOnUse'%20gradientTransform='translate(0%200)'%3e%3cstop%20id='ewMkZ6d8Hun2-fill-0'%20offset='0%25'%20stop-color='%23FF2F00'/%3e%3cstop%20id='ewMkZ6d8Hun2-fill-1'%20offset='100%25'%20stop-color='%23FF9100'/%3e%3c/linearGradient%3e%3clinearGradient%20id='ewMkZ6d8Hun3-fill'%20x1='31.5059'%20y1='27.1026'%20x2='10.2884'%20y2='14.9373'%20spreadMethod='pad'%20gradientUnits='userSpaceOnUse'%20gradientTransform='translate(0%200)'%3e%3cstop%20id='ewMkZ6d8Hun3-fill-0'%20offset='4.7%25'%20stop-color='%23FF2F00'/%3e%3cstop%20id='ewMkZ6d8Hun3-fill-1'%20offset='100%25'%20stop-color='%23FF9100'/%3e%3c/linearGradient%3e%3c/defs%3e%3cg%20id='ewMkZ6d8Hun2_ts'%20transform='translate(24.943161,19.954806)%20scale(1,1)'%3e%3cpath%20d='M14.8466,29.2814c0,0-14.408088-4.6983-12.05895-19.79995c0,0,1.50345,4.85085,4.13448,5.30845s-2.03592,4.6373,7.92447,14.4915Z'%20transform='translate(-24.943161,-19.954806)'%20fill='url(%23ewMkZ6d8Hun2-fill)'/%3e%3c/g%3e%3cg%20id='ewMkZ6d8Hun3_ts'%20transform='translate(24.9787,20.012362)%20scale(1,1)'%3e%3cpath%20d='M37.4922,21.9282l4.0719.244v-12.81353C31.0713,3.28748,17.7595,7.6502,17.7595,7.6502c.3445-4.51526-3.5707-5.52204-3.5707-5.52204c2.5371,1.52542.3132,6.22373.3132,6.22373C13.0299,0.084092,0,1.02986,0,1.02986C8.92672,4.35528,6.70287,7.98579,6.8908,16.6197c.18794,8.6034,8.3943,12.9966,8.3943,12.9966l-6.60895-.2441v13.2407c0,0,5.48135,2.3797,13.68765,3.1729v-22.3017h-4.4477c-1.0023,0-1.942-.8237-1.942-1.8v-5.7356c0-.9763.9397-1.8,1.942-1.8h4.4477v-1.3424h5.0115v1.3424h5.0115c1.0023,0,1.848.7932,1.848,1.8v5.7356c0,.9763-.8144,1.8-1.848,1.8h-5.0115v22.5153h.2819c11.1192-.0611,15.9428-7.3221,16.256-13.3017.4698-7.7492-6.421-10.7695-6.421-10.7695Z'%20transform='translate(-24.9787,-20.012361)'%20fill='url(%23ewMkZ6d8Hun3-fill)'/%3e%3c/g%3e%3c/svg%3e)
Latest Research & News
The Rosen Law Firm is investigating potential securities claims against Azenta, Inc. (NASDAQ: AZTA) following allegations of materially misleading business information. The investigation was triggered by the resignation of President and CEO John P. Marotta on August 22, 2026, which caused Azenta's stock to fall 12% on August 24, 2026. Investors who purchased Azenta securities may be eligible to join a class action lawsuit seeking recovery of losses.
11/09/2026, 5:42 PM • GlobeNewswire
Rosen Law Firm is notifying investors about ongoing securities class action lawsuits against Lincoln Educational Services Corporation (LINC), Qfin Holdings, Inc. (QFIN), and Azenta, Inc. The lawsuit against LINC alleges the company made false statements about its admissions process and student enrollment conversion rates. Investors who purchased securities during specified periods are encouraged to seek counsel, with a November 10, 2026 deadline for lead plaintiff claims.
11/05/2026, 6:33 PM • GlobeNewswire
Rosen Law Firm is investigating potential securities claims against Azenta, Inc. (NASDAQ: AZTA) for allegedly issuing materially misleading business information. The investigation was prompted by CEO John P. Marotta's resignation on August 22, 2026, which triggered a 12% stock decline on August 24, 2026. The firm is preparing a class action lawsuit to recover investor losses.
10/30/2026, 4:40 PM • GlobeNewswire
Multiple law firms have announced investigations into potential securities fraud claims against several companies including Beneficient (BENF), J.B. Hunt Transport Services, and Azenta, Inc., alleging materially misleading business information. Investors who suffered losses are encouraged to join class action lawsuits. Additional class action reminders were issued for Flotek Industries, York Space Systems (YSS), and Innventure (INV) with approaching deadlines.
10/25/2026, 9:51 AM • GlobeNewswire
The Rosen Law Firm is investigating potential securities claims against Azenta, Inc. following the unexpected resignation of President and CEO John P. Marotta on August 22, 2026. The announcement triggered a 12% stock price decline on August 24, 2026. Investors who purchased Azenta securities may be eligible to join a class action lawsuit seeking compensation for losses.
10/25/2026, 9:48 AM • GlobeNewswire
The Rosen Law Firm has announced investigations into potential securities claims against multiple companies including Fervo Energy Company (NASDAQ: FRVO), Triller Group Inc., and Azenta, Inc., alleging that these companies may have issued materially misleading business information to investors. The firm is preparing class action lawsuits seeking recovery of investor losses through contingency fee arrangements.
10/16/2026, 9:37 PM • GlobeNewswire
The Rosen Law Firm is investigating potential securities claims against Azenta, Inc. following the resignation of President and CEO John P. Marotta on August 22, 2026. The announcement triggered a 12% stock decline on August 24, 2026. The firm is preparing a class action lawsuit to recover investor losses related to allegations of materially misleading business information.
10/16/2026, 9:21 PM • GlobeNewswire
Rosen Law Firm is investigating potential securities claims against Azenta, Inc. following allegations of materially misleading business information. The investigation was prompted by CEO John P. Marotta's resignation on August 22, 2026, which triggered a 12% stock decline on August 24, 2026. The firm is preparing a class action lawsuit to recover investor losses.
10/09/2026, 5:49 PM • GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Azenta, Inc. - AZTA
Pomerantz LLP is investigating potential securities fraud at Azenta, Inc. following the resignation of CEO John Marotta on August 24, 2026. The announcement triggered a significant stock price decline of 12.09% ($4.52 per share), closing at $32.88. Investors are being invited to join a class action lawsuit.
09/01/2026, 7:48 PM • GlobeNewswire
Azenta, Inc. (AZTA) faces an ongoing securities fraud investigation following disappointing Q2 2026 earnings results on May 5, 2026. The company missed consensus estimates, reported a $149 million goodwill impairment, and significantly reduced its 2026 guidance, causing the stock to plummet 25.3% to $18.38 per share. A securities law firm is investigating potential federal securities law violations and urging affected shareholders to contact them.
05/22/2026, 1:21 PM • Benzinga
Levi & Korsinsky Announces Investigation of Securities Claims Against Azenta, Inc. (AZTA)
Azenta, Inc. reaffirmed 3%-5% organic revenue growth and 300 basis points of margin expansion in February 2026, but disclosed a $149 million goodwill impairment tied to its Multiomics segment in May 2026, alongside a $160.8 million net loss and substantial guidance reduction. The company did not reference the impairment risk during its February reaffirmation, prompting an investigation into potential securities law violations.
05/21/2026, 9:00 AM • GlobeNewswire
Law firm Bragar Eagel & Squire is investigating Azenta, Inc. following the company's May 5, 2026 announcement of disappointing Q2 fiscal 2026 results, execution gaps, and a $149 million goodwill impairment charge. Azenta significantly lowered its full-year guidance and extended its long-range plan targets, causing its stock to plummet 25% from $24.61 to $18.38 per share.
05/19/2026, 6:23 PM • GlobeNewswire
Azenta, Inc. reported disappointing Q2 fiscal 2026 results with execution gaps and weak demand, recording a $149 million goodwill impairment charge. The company significantly reduced its full-year guidance and extended long-range plan targets, causing its stock to plunge 25% on May 6, 2026. Law firm Kirby McInerney LLP is investigating potential securities law violations by the company and its senior management.
05/18/2026, 7:00 PM • GlobeNewswire
AZTA Investors Have Opportunity to Join Azenta, Inc. Fraud Investigation with the Schall Law Firm
The Schall Law Firm announced an investigation into Azenta, Inc. for potential securities law violations following the company's May 5, 2026 earnings announcement. Azenta missed analyst estimates on revenue and EPS due to execution shortfalls and weak demand, leading to a 25.3% stock price decline and a reduced full-year 2026 outlook.
05/18/2026, 2:43 PM • GlobeNewswire
Azenta, Inc. (NASDAQ: AZTA) recorded a $149 million goodwill impairment and slashed FY 2026 guidance on May 5, 2026, just weeks after reaffirming confidence in its growth trajectory on the Q1 earnings call. The impairment was tied to the Multiomics segment. Levi & Korsinsky is investigating whether the company made materially misleading statements to investors regarding risks to the Multiomics segment and factors underlying the goodwill impairment.
05/14/2026, 9:00 AM • GlobeNewswire
Peers
Statistics
MoreInformation as of 11/10/2026
Company Profile
Azenta, Inc. provides biological and chemical compound sample exploration and management solutions for the life sciences industry in the United States, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. It operates through Sample Management Solutions and Multiomics segments. The Sample Management Solutions segment provides sample management products and services, including automated stores, cryogenic systems, automated sample tubes, consumables and instruments, and controlled rate thawing devices, as well as sample repository services. This segment also offers consultation services to clients throughout their experimental design and implementation processes. The Multiomics segment provides genomic and other sample analysis services comprising gene sequencing, gene synthesis, and related services. The company has a strategic partnership with Frontier Space Ltd to conduct scientific experiments in space. The company was formerly known as Brooks Automation, Inc. and changed its name to Azenta, Inc. in December 2021. Azenta, Inc. was founded in 1978 and is headquartered in Burlington, Massachusetts.